Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 2233 to 2242 of 2242 entries
Sorted by: Best Match Show Resources per page
Muscle damage in response to a single bout of high intensity concentric exercise in patients with Pompe disease.

Annals of translational medicine

Váczi M, Nagy SA, Kőszegi T, Misovics B, Szabó E, Müller É, Perlaki G, Orsi G, Pál J, Bogner P, Illes Z.
PMID: 33842610
Ann Transl Med. 2021 Mar;9(5):389. doi: 10.21037/atm-20-3114.

BACKGROUND: In Pompe disease, resistance exercise could be an effective treatment to delay motor function impairment, however, the acute effects of this exercise modality are unclear.METHODS: In a prospective cohort study, we compared responses to a single bout of...

Cite
Váczi M, Nagy SA, Kőszegi T, et al. Muscle damage in response to a single bout of high intensity concentric exercise in patients with Pompe disease. Ann Transl Med. 2021;9(5):389doi: 10.21037/atm-20-3114.
Váczi, M., Nagy, S. A., Kőszegi, T., Misovics, B., Szabó, E., Müller, �. �., Perlaki, G., Orsi, G., Pál, J., Bogner, P., & Illes, Z. (2021). Muscle damage in response to a single bout of high intensity concentric exercise in patients with Pompe disease. Annals of translational medicine, 9(5), 389. https://doi.org/10.21037/atm-20-3114
Váczi, Márk, et al. "Muscle damage in response to a single bout of high intensity concentric exercise in patients with Pompe disease." Annals of translational medicine vol. 9,5 (2021): 389. doi: https://doi.org/10.21037/atm-20-3114
Váczi M, Nagy SA, Kőszegi T, Misovics B, Szabó E, Müller É, Perlaki G, Orsi G, Pál J, Bogner P, Illes Z. Muscle damage in response to a single bout of high intensity concentric exercise in patients with Pompe disease. Ann Transl Med. 2021 Mar;9(5):389. doi: 10.21037/atm-20-3114. PMID: 33842610; PMCID: PMC8033309.
Copy Download .nbib Format: NLM
Do serum markers correlate with invasiveness of the procedure in THA? A prospective randomized study comparing direct anterior and lateral approaches.

Orthopaedics & traumatology, surgery & research : OTSR

Iorio R, Viglietta E, Mazza D, Iannotti F, Nicolosi I, Carrozzo A, Speranza A, Ferretti A.
PMID: 33895386
Orthop Traumatol Surg Res. 2021 Dec;107(8):102937. doi: 10.1016/j.otsr.2021.102937. Epub 2021 Apr 22.

BACKGROUND: Advantages of minimally invasive approaches for total hip arthroplasty are still matter of debate. Serum markers have been assessed as objective method to quantify muscle damage after surgery but in literature ambiguous results have been reported. The aim...

Cite
Iorio R, Viglietta E, Mazza D, et al. Do serum markers correlate with invasiveness of the procedure in THA? A prospective randomized study comparing direct anterior and lateral approaches. Orthop Traumatol Surg Res. 2021;107(8):102937doi: 10.1016/j.otsr.2021.102937.
Iorio, R., Viglietta, E., Mazza, D., Iannotti, F., Nicolosi, I., Carrozzo, A., Speranza, A., & Ferretti, A. (2021). Do serum markers correlate with invasiveness of the procedure in THA? A prospective randomized study comparing direct anterior and lateral approaches. Orthopaedics & traumatology, surgery & research : OTSR, 107(8), 102937. https://doi.org/10.1016/j.otsr.2021.102937
Iorio, Raffaele, et al. "Do serum markers correlate with invasiveness of the procedure in THA? A prospective randomized study comparing direct anterior and lateral approaches." Orthopaedics & traumatology, surgery & research : OTSR vol. 107,8 (2021): 102937. doi: https://doi.org/10.1016/j.otsr.2021.102937
Iorio R, Viglietta E, Mazza D, Iannotti F, Nicolosi I, Carrozzo A, Speranza A, Ferretti A. Do serum markers correlate with invasiveness of the procedure in THA? A prospective randomized study comparing direct anterior and lateral approaches. Orthop Traumatol Surg Res. 2021 Dec;107(8):102937. doi: 10.1016/j.otsr.2021.102937. Epub 2021 Apr 22. PMID: 33895386.
Copy Download .nbib Format: NLM
Recurrent Exercise-Induced Rhabdomyolysis in a Healthy Adolescent Girl.

Cureus

Longobardi NC, Longobardi Y.
PMID: 33329960
Cureus. 2020 Nov 12;12(11):e11462. doi: 10.7759/cureus.11462.

Female symptomatic carriers of Duchenne muscular dystrophy (DMD) are uncommon findings. Much of this disease has been studied from a male perspective, but female disease presentation and progression are rarely described. This report describes a female adolescent patient with...

Cite
Longobardi NC, Longobardi Y. Recurrent Exercise-Induced Rhabdomyolysis in a Healthy Adolescent Girl. Cureus. 2020;12(11):e11462doi: 10.7759/cureus.11462.
Longobardi, N. C., & Longobardi, Y. (2020). Recurrent Exercise-Induced Rhabdomyolysis in a Healthy Adolescent Girl. Cureus, 12(11), e11462. https://doi.org/10.7759/cureus.11462
Longobardi, Nicolas C, and Longobardi, Yen. "Recurrent Exercise-Induced Rhabdomyolysis in a Healthy Adolescent Girl." Cureus vol. 12,11 (2020): e11462. doi: https://doi.org/10.7759/cureus.11462
Longobardi NC, Longobardi Y. Recurrent Exercise-Induced Rhabdomyolysis in a Healthy Adolescent Girl. Cureus. 2020 Nov 12;12(11):e11462. doi: 10.7759/cureus.11462. PMID: 33329960; PMCID: PMC7733763.
Copy Download .nbib Format: NLM
Plasma exchange therapy in refractory inflammatory myopathy with anti-signal recognition particle antibody: a case series.

Rheumatology (Oxford, England)

Zhang H, Sun Y, Liu H, Cheng X, Ye J, Hu Q, Jia J, Wang M, Liu T, Zhou Z, Yang C, Chi H, Teng J, Su Y.
PMID: 34508561
Rheumatology (Oxford). 2021 Sep 11; doi: 10.1093/rheumatology/keab629. Epub 2021 Sep 11.

OBJECTIVES: To explore the efficacy of plasma exchange (PE) therapy in refractory idiopathic inflammatory myopathy (IIM) patients with positive anti-signal recognition particle (SRP) antibody.METHODS: Nine refractory IIM patients with positive anti-SRP antibody were enrolled, who received PE therapy at...

Cite
Zhang H, Sun Y, Liu H, et al. Plasma exchange therapy in refractory inflammatory myopathy with anti-signal recognition particle antibody: a case series. Rheumatology (Oxford). 2021;doi: 10.1093/rheumatology/keab629.
Zhang, H., Sun, Y., Liu, H., Cheng, X., Ye, J., Hu, Q., Jia, J., Wang, M., Liu, T., Zhou, Z., Yang, C., Chi, H., Teng, J., & Su, Y. (2021). Plasma exchange therapy in refractory inflammatory myopathy with anti-signal recognition particle antibody: a case series. Rheumatology (Oxford, England), . https://doi.org/10.1093/rheumatology/keab629
Zhang, Hao, et al. "Plasma exchange therapy in refractory inflammatory myopathy with anti-signal recognition particle antibody: a case series." Rheumatology (Oxford, England) vol. (2021). doi: https://doi.org/10.1093/rheumatology/keab629
Zhang H, Sun Y, Liu H, Cheng X, Ye J, Hu Q, Jia J, Wang M, Liu T, Zhou Z, Yang C, Chi H, Teng J, Su Y. Plasma exchange therapy in refractory inflammatory myopathy with anti-signal recognition particle antibody: a case series. Rheumatology (Oxford). 2021 Sep 11; doi: 10.1093/rheumatology/keab629. Epub 2021 Sep 11. PMID: 34508561.
Copy Download .nbib Format: NLM
Vanillin modulates activities linked to dysmetabolism in psoas muscle of diabetic rats.

Scientific reports

Salau VF, Erukainure OL, Olofinsan KA, Ijomone OM, Msomi NZ, Islam MS.
PMID: 34548565
Sci Rep. 2021 Sep 21;11(1):18724. doi: 10.1038/s41598-021-98158-7.

Skeletal muscles are important in glucose metabolism and are affected in type 2 diabetes (T2D) and its complications. This study investigated the effect of vanillin on redox imbalance, cholinergic and purinergic dysfunction, and glucose-lipid dysmetabolism in muscles of rats...

Cite
Salau VF, Erukainure OL, Olofinsan KA, et al. Vanillin modulates activities linked to dysmetabolism in psoas muscle of diabetic rats. Sci Rep. 2021;11(1):18724doi: 10.1038/s41598-021-98158-7.
Salau, V. F., Erukainure, O. L., Olofinsan, K. A., Ijomone, O. M., Msomi, N. Z., & Islam, M. S. (2021). Vanillin modulates activities linked to dysmetabolism in psoas muscle of diabetic rats. Scientific reports, 11(1), 18724. https://doi.org/10.1038/s41598-021-98158-7
Salau, Veronica F, et al. "Vanillin modulates activities linked to dysmetabolism in psoas muscle of diabetic rats." Scientific reports vol. 11,1 (2021): 18724. doi: https://doi.org/10.1038/s41598-021-98158-7
Salau VF, Erukainure OL, Olofinsan KA, Ijomone OM, Msomi NZ, Islam MS. Vanillin modulates activities linked to dysmetabolism in psoas muscle of diabetic rats. Sci Rep. 2021 Sep 21;11(1):18724. doi: 10.1038/s41598-021-98158-7. PMID: 34548565; PMCID: PMC8455626.
Copy Download .nbib Format: NLM
Frequency of Cardiovascular Complications and Its Association with Prognosis of COVID-19 Patients.

BioMed research international

Mazaherpour H, Soofian M, Farahani E, Masfari Farahani F, Ghaznavi Rad E, Mazaherpour S, Ramazani Y, Ashrafian F, Ramezani A.
PMID: 34901278
Biomed Res Int. 2021 Dec 08;2021:7073348. doi: 10.1155/2021/7073348. eCollection 2021.

Coronavirus disease 2019 (COVID-19) may lead to acute respiratory disease; cardiovascular, gastrointestinal, and coagulation complications; and even death. One of the major complications is cardiovascular disorders, including arrhythmias, myocarditis, pericarditis, and acute coronary artery disease. The aim of this...

Cite
Mazaherpour H, Soofian M, Farahani E, et al. Frequency of Cardiovascular Complications and Its Association with Prognosis of COVID-19 Patients. Biomed Res Int. 2021;2021:7073348doi: 10.1155/2021/7073348.
Mazaherpour, H., Soofian, M., Farahani, E., Masfari Farahani, F., Ghaznavi Rad, E., Mazaherpour, S., Ramazani, Y., Ashrafian, F., & Ramezani, A. (2021). Frequency of Cardiovascular Complications and Its Association with Prognosis of COVID-19 Patients. BioMed research international, 20217073348. https://doi.org/10.1155/2021/7073348
Mazaherpour, Hossein, et al. "Frequency of Cardiovascular Complications and Its Association with Prognosis of COVID-19 Patients." BioMed research international vol. 2021 (2021): 7073348. doi: https://doi.org/10.1155/2021/7073348
Mazaherpour H, Soofian M, Farahani E, Masfari Farahani F, Ghaznavi Rad E, Mazaherpour S, Ramazani Y, Ashrafian F, Ramezani A. Frequency of Cardiovascular Complications and Its Association with Prognosis of COVID-19 Patients. Biomed Res Int. 2021 Dec 08;2021:7073348. doi: 10.1155/2021/7073348. eCollection 2021. PMID: 34901278; PMCID: PMC8654567.
Copy Download .nbib Format: NLM
Effect of N‑terminal region of human parvovirus B19‑VP1 unique region on cardiac injury in naïve mice.

Molecular medicine reports

Hung KC, Huang ZY, Yow JL, Hsu TC, Tzang BS.
PMID: 34476499
Mol Med Rep. 2021 Nov;24(5). doi: 10.3892/mmr.2021.12399. Epub 2021 Sep 03.

A unique region of human parvovirus B19 virus‑VP1 (B19V‑VP1u) has been linked to a variety of cardiac disorders. However, the precise role of B19V‑VP1u in inducing cardiac injury remains unknown. The present study investigated the effects of B19V‑VP1u and...

Cite
Hung KC, Huang ZY, Yow JL, et al. Effect of N‑terminal region of human parvovirus B19‑VP1 unique region on cardiac injury in naïve mice. Mol Med Rep. 2021;24(5)doi: 10.3892/mmr.2021.12399.
Hung, K. C., Huang, Z. Y., Yow, J. L., Hsu, T. C., & Tzang, B. S. (2021). Effect of N‑terminal region of human parvovirus B19‑VP1 unique region on cardiac injury in naïve mice. Molecular medicine reports, 24(5), . https://doi.org/10.3892/mmr.2021.12399
Hung, Kuo-Chuan, et al. "Effect of N‑terminal region of human parvovirus B19‑VP1 unique region on cardiac injury in naïve mice." Molecular medicine reports vol. 24,5 (2021). doi: https://doi.org/10.3892/mmr.2021.12399
Hung KC, Huang ZY, Yow JL, Hsu TC, Tzang BS. Effect of N‑terminal region of human parvovirus B19‑VP1 unique region on cardiac injury in naïve mice. Mol Med Rep. 2021 Nov;24(5). doi: 10.3892/mmr.2021.12399. Epub 2021 Sep 03. PMID: 34476499; PMCID: PMC8436207.
Copy Download .nbib Format: NLM
Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies.

Journal of autoimmunity

Arase N, Tsuji H, Takamatsu H, Jin H, Konaka H, Hamaguchi Y, Tonomura K, Kotobuki Y, Ueda-Hayakawa I, Matsuoka S, Hirano T, Yorifuji H, Murota H, Ohmura K, Nakashima R, Sato T, Kumanogoh A, Katayama I, Arase H, Fujimoto M.
PMID: 34896887
J Autoimmun. 2021 Dec 09;126:102774. doi: 10.1016/j.jaut.2021.102774. Epub 2021 Dec 09.

Intracellular proteins are often targeted by autoantibodies in autoimmune diseases; however, the mechanism through which intracellular molecules are targeted remains unknown. We previously found that several intracellular misfolded proteins are transported to the cell surface by HLA class II...

Cite
Arase N, Tsuji H, Takamatsu H, et al. Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies. J Autoimmun. 2021;126:102774doi: 10.1016/j.jaut.2021.102774.
Arase, N., Tsuji, H., Takamatsu, H., Jin, H., Konaka, H., Hamaguchi, Y., Tonomura, K., Kotobuki, Y., Ueda-Hayakawa, I., Matsuoka, S., Hirano, T., Yorifuji, H., Murota, H., Ohmura, K., Nakashima, R., Sato, T., Kumanogoh, A., Katayama, I., Arase, H., & Fujimoto, M. (2021). Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies. Journal of autoimmunity, 126102774. https://doi.org/10.1016/j.jaut.2021.102774
Arase, Noriko, et al. "Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies." Journal of autoimmunity vol. 126 (2021): 102774. doi: https://doi.org/10.1016/j.jaut.2021.102774
Arase N, Tsuji H, Takamatsu H, Jin H, Konaka H, Hamaguchi Y, Tonomura K, Kotobuki Y, Ueda-Hayakawa I, Matsuoka S, Hirano T, Yorifuji H, Murota H, Ohmura K, Nakashima R, Sato T, Kumanogoh A, Katayama I, Arase H, Fujimoto M. Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies. J Autoimmun. 2021 Dec 09;126:102774. doi: 10.1016/j.jaut.2021.102774. Epub 2021 Dec 09. PMID: 34896887.
Copy Download .nbib Format: NLM
Incidence and risk factors of acute encephalopathy with biphasic seizures in febrile status epilepticus.

Brain & development

Ichinose F, Nakamura T, Kira R, Furuno K, Ishii S, Takamura K, Hashiguchi M, Inoue T, Senju A, Ichimiya Y, Sakakibara T, Sugiyama N, Naitou T, Higuchi N, Togawa M, Torii KI, Toda S, Iwamatsu H, Sato T, Tsurui S, Tanaka H, Motobayashi M, Abe A, Kawaguchi A, Matsuo M.
PMID: 34362595
Brain Dev. 2022 Jan;44(1):36-43. doi: 10.1016/j.braindev.2021.07.004. Epub 2021 Aug 03.

OBJECTIVE: To clarify the incidence and risk factors of acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) in pediatric patients with febrile status epilepticus (FSE).METHODS: We retrospectively surveyed patients with FSE (≥20 min and ≥40 min) who...

Cite
Ichinose F, Nakamura T, Kira R, et al. Incidence and risk factors of acute encephalopathy with biphasic seizures in febrile status epilepticus. Brain Dev. 2021;44(1):36-43doi: 10.1016/j.braindev.2021.07.004.
Ichinose, F., Nakamura, T., Kira, R., Furuno, K., Ishii, S., Takamura, K., Hashiguchi, M., Inoue, T., Senju, A., Ichimiya, Y., Sakakibara, T., Sugiyama, N., Naitou, T., Higuchi, N., Togawa, M., Torii, K. I., Toda, S., Iwamatsu, H., Sato, T., Tsurui, S., Tanaka, H., Motobayashi, M., Abe, A., Kawaguchi, A., & Matsuo, M. (2022). Incidence and risk factors of acute encephalopathy with biphasic seizures in febrile status epilepticus. Brain & development, 44(1), 36-43. https://doi.org/10.1016/j.braindev.2021.07.004
Ichinose, Fumio, et al. "Incidence and risk factors of acute encephalopathy with biphasic seizures in febrile status epilepticus." Brain & development vol. 44,1 (2022): 36-43. doi: https://doi.org/10.1016/j.braindev.2021.07.004
Ichinose F, Nakamura T, Kira R, Furuno K, Ishii S, Takamura K, Hashiguchi M, Inoue T, Senju A, Ichimiya Y, Sakakibara T, Sugiyama N, Naitou T, Higuchi N, Togawa M, Torii KI, Toda S, Iwamatsu H, Sato T, Tsurui S, Tanaka H, Motobayashi M, Abe A, Kawaguchi A, Matsuo M. Incidence and risk factors of acute encephalopathy with biphasic seizures in febrile status epilepticus. Brain Dev. 2022 Jan;44(1):36-43. doi: 10.1016/j.braindev.2021.07.004. Epub 2021 Aug 03. PMID: 34362595.
Copy Download .nbib Format: NLM
Increased Rates of Rhabdomyolysis in Male Hematopoietic Cell Transplantation Recipients Taking Sirolimus and Trimethoprim/Sulfamethoxazole.

Transplantation and cellular therapy

Lew J, Fitzhugh CD, Tisdale JF, Hsieh MM.
PMID: 34419651
Transplant Cell Ther. 2021 Dec;27(12):1019.e1-1019.e4. doi: 10.1016/j.jtct.2021.08.011. Epub 2021 Aug 19.

Hematopoietic cell transplantation (HCT) offers long-term cure against early morbidity and mortality of hemoglobinopathies, such as sickle cell disease (SCD) and beta-thalassemia. Following HCT, sirolimus is an immunosuppressant used to prevent graft-versus-host disease (GVHD) while receiving trimethoprim-sulfamethoxazole (TMP-SMX) for...

Cite
Lew J, Fitzhugh CD, Tisdale JF, et al. Increased Rates of Rhabdomyolysis in Male Hematopoietic Cell Transplantation Recipients Taking Sirolimus and Trimethoprim/Sulfamethoxazole. Transplant Cell Ther. 2021;27(12):1019.e1-1019.e4doi: 10.1016/j.jtct.2021.08.011.
Lew, J., Fitzhugh, C. D., Tisdale, J. F., & Hsieh, M. M. (2021). Increased Rates of Rhabdomyolysis in Male Hematopoietic Cell Transplantation Recipients Taking Sirolimus and Trimethoprim/Sulfamethoxazole. Transplantation and cellular therapy, 27(12), 1019.e1-1019.e4. https://doi.org/10.1016/j.jtct.2021.08.011
Lew, Jeffrey, et al. "Increased Rates of Rhabdomyolysis in Male Hematopoietic Cell Transplantation Recipients Taking Sirolimus and Trimethoprim/Sulfamethoxazole." Transplantation and cellular therapy vol. 27,12 (2021): 1019.e1-1019.e4. doi: https://doi.org/10.1016/j.jtct.2021.08.011
Lew J, Fitzhugh CD, Tisdale JF, Hsieh MM. Increased Rates of Rhabdomyolysis in Male Hematopoietic Cell Transplantation Recipients Taking Sirolimus and Trimethoprim/Sulfamethoxazole. Transplant Cell Ther. 2021 Dec;27(12):1019.e1-1019.e4. doi: 10.1016/j.jtct.2021.08.011. Epub 2021 Aug 19. PMID: 34419651.
Copy Download .nbib Format: NLM
Showing 2233 to 2242 of 2242 entries